Atlas Trials

A Follow-on Study of the Long-Term Safety of Aripiprazole in Patients With Chronic Schizophrenia

Clinical trial NCT02435836 · TERMINATED

Trial details

NCT number
NCT02435836
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Schizophrenia
Start date
1998-04-01
Primary completion
2012-12-01
Enrollment
631

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.